Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Clinical trial NCT04377620 · TERMINATED
Trial details
- NCT number
- NCT04377620
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-24
- Primary completion
- 2021-02-26
- Enrollment
- 211
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.